Mortality during Polymicrobial Sepsis Intestinal Barrier Dysfunction and Increased Cyclooxygenase-2 Deficiency Leads to
暂无分享,去创建一个
R. Blumberg | J. Englert | S. Chung | L. Fredenburgh | M. Perrella | M. Cernadas | Xiaoli Liu | Torsten Olszak | Rebecca | M. Baron | Padera | S. R. Walsh | C. Begay | F. Robert | Ma | M. M. S. Velandia
[1] M. Frey,et al. TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[2] A. Norrby-Teglund,et al. Inducible Cyclooxygenase Released Prostaglandin E2 Modulates the Severity of Infection Caused by Streptococcus pyogenes , 2010, The Journal of Immunology.
[3] M. Washington,et al. p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. , 2010, The Journal of clinical investigation.
[4] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[5] L. Lindgren,et al. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] A. M. Houghton,et al. Macrophage elastase kills bacteria within murine macrophages , 2009, Nature.
[7] M. Boivin,et al. Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.
[8] Jun Luo,et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis , 2008, Modern Pathology.
[9] D. Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.
[10] D. Ingber,et al. Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells , 2008, Circulation.
[11] S. Chung,et al. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.
[12] D. Rittirsch,et al. Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.
[13] H. Kleinert,et al. Regulation of cyclooxygenase-2 expression by cyclic AMP. , 2007, Biochimica et biophysica acta.
[14] J. Christman,et al. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2 , 2007, European journal of immunology.
[15] A. Blikslager,et al. Restoration of barrier function in injured intestinal mucosa. , 2007, Physiological reviews.
[16] D. Aronoff,et al. Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.
[17] C. Macias,et al. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. , 2006, American journal of physiology. Cell physiology.
[18] R. Poulsom,et al. Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis. , 2006, Carcinogenesis.
[19] D. Remick,et al. EVALUATION OF ENDOTOXIN MODELS FOR THE STUDY OF SEPSIS , 2005, Shock.
[20] James J. Lee,et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[21] L. Fredenburgh,et al. Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. , 2005, Cellular and molecular biology.
[22] V. Théodorou,et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. , 2005, The American journal of pathology.
[23] T. Brzozowski,et al. Role of prostaglandins in gastroprotection and gastric adaptation. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[24] J. Wallace,et al. Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense , 2005, British journal of pharmacology.
[25] M. Fink,et al. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. , 2005, Critical care clinics.
[26] R. Griffiths,et al. Intestinal permeability in the critically ill , 2005, Intensive Care Medicine.
[27] E. Ingenito,et al. Nitric oxide synthase‐2 down‐regulates surfactant protein‐B expression and enhances endotoxin‐induced lung injury in mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] D. Aronoff,et al. Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.
[29] V. Angeli,et al. Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. , 2004, Critical reviews in immunology.
[30] M. Fink,et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[31] B. Levy,et al. Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] M. Fink,et al. Proinflammatory Cytokines Cause No·-Dependent and -Independent Changes in Expression and Localization of Tight Junction Proteins in Intestinal Epithelial Cells , 2003, Shock.
[33] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[34] M. Fink,et al. Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers , 2003, Journal of Pharmacology and Experimental Therapeutics.
[35] A. Nathens,et al. Risk factors for severe sepsis in secondary peritonitis. , 2003, Surgical infections.
[36] M. Freeman,et al. Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 , 2002, The Journal of Immunology.
[37] M. Fink,et al. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[38] Yoshihiro Urade,et al. Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.
[39] J. Wallace. PROSTAGLANDIAN BIOLOGY IN INFLAMMATORY BOWEL DISEASE , 2001 .
[40] B. Schreiber,et al. Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] T. Standiford,et al. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[42] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[43] B. Schreiber,et al. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] H. Rennke,et al. Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.
[45] R. Hershberg,et al. Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.
[46] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[47] J. Wallace. Prostaglandin biology in inflammatory bowel disease. , 2001, Gastroenterology clinics of North America.
[48] C. Houchen,et al. Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[49] J. Wallace,et al. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.
[50] T. Uliasz,et al. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture , 2000, Journal of Neuroscience Methods.
[51] J. Wallace,et al. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[52] R. Sartor,et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. , 2000, The Journal of clinical investigation.
[53] Rian,et al. THE EFFECTS OF IBUPROFEN ON THE PHYSIOLOGY AND SURVIVAL OF PATIENTS WITH SEPSIS , 2000 .
[54] M. Respondek,et al. Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach , 1999, British journal of pharmacology.
[55] M. Fink,et al. Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. , 1999, Shock.
[56] A. Ford-hutchinson,et al. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. , 1999, European journal of pharmacology.
[57] Han,et al. Specific NF‐κB blockade selectively inhibits tumour necrosis factor‐α‐induced COX‐2 but not constitutive COX‐1 gene expression in HT‐29 cells , 1998, Immunology.
[58] C. Koboldt,et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[59] C. Doig,et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. , 1998, American journal of respiratory and critical care medicine.
[60] J. Mazuski,et al. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. , 1998, Prostaglandins & other lipid mediators.
[61] I. Singer,et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.
[62] J. R. Smith,et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.
[63] H. Sheng,et al. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[64] G. Bernard,et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.
[65] K. Seibert,et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.
[66] J. Wallace,et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.
[67] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[68] Y. Boie,et al. Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.
[69] H. Chan,et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.
[70] S. Narumiya,et al. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[71] C. Rodning,et al. Tumor Necrosis Factor‐Induced Mortality Is Reversed with Cyclooxygenase Inhibition , 1993, Annals of surgery.
[72] P. Rangachari,et al. Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. , 1991, The American journal of physiology.
[73] U. Haglund,et al. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. , 1990, Surgery.
[74] Y. Urade,et al. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.
[75] W. Stok,et al. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. , 1987, Journal of immunological methods.
[76] T. Grosser,et al. PROSTANOIDS IN HEALTH AND DISEASE , 1979 .
[77] H. Scott,et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.
[78] M. Frey,et al. TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[79] A. Norrby-Teglund,et al. Inducible Cyclooxygenase Released Prostaglandin E2 Modulates the Severity of Infection Caused by Streptococcus pyogenes , 2010, The Journal of Immunology.
[80] M. Washington,et al. p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. , 2010, The Journal of clinical investigation.
[81] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[82] L. Lindgren,et al. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[83] A. M. Houghton,et al. Macrophage elastase kills bacteria within murine macrophages , 2009, Nature.
[84] M. Boivin,et al. Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.
[85] Jun Luo,et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis , 2008, Modern Pathology.
[86] D. Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.
[87] D. Ingber,et al. Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells , 2008, Circulation.
[88] S. Chung,et al. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.
[89] D. Rittirsch,et al. Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.
[90] H. Kleinert,et al. Regulation of cyclooxygenase-2 expression by cyclic AMP. , 2007, Biochimica et biophysica acta.
[91] J. Christman,et al. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2 , 2007, European journal of immunology.
[92] A. Blikslager,et al. Restoration of barrier function in injured intestinal mucosa. , 2007, Physiological reviews.
[93] D. Aronoff,et al. Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.
[94] C. Macias,et al. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. , 2006, American journal of physiology. Cell physiology.
[95] R. Poulsom,et al. Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis. , 2006, Carcinogenesis.
[96] D. Remick,et al. EVALUATION OF ENDOTOXIN MODELS FOR THE STUDY OF SEPSIS , 2005, Shock.
[97] James J. Lee,et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[98] L. Fredenburgh,et al. Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels. , 2005, Cellular and molecular biology.
[99] V. Théodorou,et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. , 2005, The American journal of pathology.
[100] T. Brzozowski,et al. Role of prostaglandins in gastroprotection and gastric adaptation. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[101] J. Wallace,et al. Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense , 2005, British journal of pharmacology.
[102] M. Fink,et al. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. , 2005, Critical care clinics.
[103] R. Griffiths,et al. Intestinal permeability in the critically ill , 2005, Intensive Care Medicine.
[104] E. Ingenito,et al. Nitric oxide synthase‐2 down‐regulates surfactant protein‐B expression and enhances endotoxin‐induced lung injury in mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[105] D. Aronoff,et al. Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.
[106] V. Angeli,et al. Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. , 2004, Critical reviews in immunology.
[107] M. Fink,et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[108] B. Levy,et al. Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[109] M. Fink,et al. Proinflammatory Cytokines Cause No·-Dependent and -Independent Changes in Expression and Localization of Tight Junction Proteins in Intestinal Epithelial Cells , 2003, Shock.
[110] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[111] M. Fink,et al. Ethyl Pyruvate Ameliorates Intestinal Epithelial Barrier Dysfunction in Endotoxemic Mice and Immunostimulated Caco-2 Enterocytic Monolayers , 2003, Journal of Pharmacology and Experimental Therapeutics.
[112] A. Nathens,et al. Risk factors for severe sepsis in secondary peritonitis. , 2003, Surgical infections.
[113] M. Freeman,et al. Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 , 2002, The Journal of Immunology.
[114] M. Fink,et al. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[115] Yoshihiro Urade,et al. Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.
[116] B. Schreiber,et al. Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[117] T. Standiford,et al. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[118] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[119] H. Rennke,et al. Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.
[120] R. Hershberg,et al. Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.
[121] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[122] J. Wallace. Prostaglandin biology in inflammatory bowel disease. , 2001, Gastroenterology clinics of North America.
[123] C. Houchen,et al. Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[124] J. Wallace,et al. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.
[125] T. Uliasz,et al. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture , 2000, Journal of Neuroscience Methods.
[126] J. Wallace,et al. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[127] R. Sartor,et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. , 2000, The Journal of clinical investigation.
[128] Rian,et al. THE EFFECTS OF IBUPROFEN ON THE PHYSIOLOGY AND SURVIVAL OF PATIENTS WITH SEPSIS , 2000 .
[129] M. Respondek,et al. Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach , 1999, British journal of pharmacology.
[130] M. Fink,et al. Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. , 1999, Shock.
[131] A. Ford-hutchinson,et al. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. , 1999, European journal of pharmacology.
[132] C. Koboldt,et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[133] C. Doig,et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. , 1998, American journal of respiratory and critical care medicine.
[134] J. Mazuski,et al. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. , 1998, Prostaglandins & other lipid mediators.
[135] I. Singer,et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. , 1998, Gastroenterology.
[136] J. R. Smith,et al. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. , 1997, The Journal of clinical investigation.
[137] H. Sheng,et al. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[138] K. Seibert,et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.
[139] J. Wallace,et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.
[140] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[141] Y. Boie,et al. Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.
[142] H. Chan,et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.
[143] S. Narumiya,et al. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[144] C. Rodning,et al. Tumor Necrosis Factor‐Induced Mortality Is Reversed with Cyclooxygenase Inhibition , 1993, Annals of surgery.
[145] P. Rangachari,et al. Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. , 1991, The American journal of physiology.
[146] U. Haglund,et al. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. , 1990, Surgery.
[147] Y. Urade,et al. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. , 1988, Archives of biochemistry and biophysics.
[148] W. Stok,et al. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. , 1987, Journal of immunological methods.
[149] T. Grosser,et al. PROSTANOIDS IN HEALTH AND DISEASE , 1979 .
[150] H. Scott,et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.